50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Arteris director Wayne Cantwell sells $104,200 worth of shares

Published 09/10/2024, 04:52 PM
AIP
-

In a recent transaction, Wayne C. Cantwell, a director at Arteris, Inc. (NASDAQ:AIP), sold 15,000 shares of the company's common stock. The sale, which took place on September 6, 2024, amounted to a total of $104,200. The shares were sold at a weighted average price of $6.9467, with individual sales prices ranging from $6.73 to $7.28.


This sale was conducted under a 10b5-1 trading plan, which Cantwell had adopted on June 7, 2024. Such plans allow company insiders to set up a predetermined schedule for buying or selling shares at a time when they are not in possession of material non-public information, thereby helping to avoid accusations of insider trading.


Following the transaction, Cantwell still holds a significant stake in Arteris, with 243,198 shares of common stock directly owned. Additionally, he has an indirect ownership of 38,761 shares through the Decathlon Capital Management 401K Plan for his benefit.


Investors and followers of Arteris, Inc. often keep an eye on insider transactions as they can provide insights into how the company's top brass view the stock's value and prospects. The details of this sale, including the number of shares sold at each separate price within the reported range, are available upon request from the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission.


In other recent news, Arteris, Inc. reported a strong Q2 performance, largely driven by AI and automotive demand. The company announced a record annual contract value plus royalties of $60.1 million for the second quarter of 2024. This robust performance is attributed to strong customer demand, the addition of seven new customers, and the signing of four new license deals with existing clients. The company also confirmed 21 design starts, primarily in the AI-enabled autonomous driving sector within the automotive industry.


Arteris expects ACV plus royalties to be between $58.5 million and $62.5 million for Q3, with revenues projected at $14.2 million to $15.2 million. For the full year of 2024, the company projects an ACV plus royalties of $62 million to $68 million and revenue of $56 million to $58 million. Despite challenges from internal system IP groups and companies pursuing specialized technology directions, Arteris is successfully securing deals with large corporations that previously relied on internal IP.


These are just some of the recent developments for Arteris, as the company continues to navigate the complexities of the semiconductor industry with a strategic focus on growth areas such as AI-driven automotive solutions and enterprise computing.


InvestingPro Insights


Arteris, Inc. (NASDAQ:AIP) director Wayne C. Cantwell's recent stock sale might raise questions among investors regarding the company's financial health and future prospects. To provide a clearer picture, let's delve into some key financial metrics and insights from InvestingPro.


The company currently holds a market capitalization of approximately $268.91 million, which gives investors a sense of its size within the industry. Despite an impressive gross profit margin of 89.39% for the last twelve months as of Q2 2024, Arteris has not been profitable over the same period, with a negative return on assets of -35.87%. This aligns with one of the InvestingPro Tips, which indicates that analysts do not anticipate the company will be profitable this year. This tip is particularly relevant following Cantwell's stock sale, as it might reflect broader market sentiments regarding the company's near-term earning potential.


Moreover, Arteris is trading at a high Price / Book multiple of 51.72, suggesting that the stock may be valued quite richly in comparison to the company's book value. This is further supported by the fact that the stock has taken a considerable hit over the last week, with a price total return of -10.92%. This could be a signal to investors that the market is adjusting its expectations for the company's valuation.


For those interested in further analysis and additional insights, there are more InvestingPro Tips available for Arteris, Inc. at https://www.investing.com/pro/AIP. These tips, which include information on earnings revisions by analysts and the company's cash versus debt position, can help investors make more informed decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.